Peter L Davis, MD
- Clinical Associate Professor of Radiology
California Institute of Technology, Pasadena, CA BS Biology
University of California, Los Angeles, CA MD
University of California, San Francisco, CA Radiology Residency
University of California, San Francisco, CA Fellowship: CT, MRI
Stanford – Online, Coursera (non-credit) Machine Learning Instructor: Andrew Ng
Stanford – Online, OpenEdX (non-credit) Statistical Learning Instructors: Trevor Hastie, Rob Tibshirani
Author or coauthor of 64 research papers, 29 review articles and chapters, and 65 published abstracts or posters.
- Davis PL, Raff GL, Glantz SA. A Method to Identify Implanted Radiopaque Markers Despite Rotation of the Heart. Am J Physiol 1980; 239 (Heart Circ. Phys. 8): H573-H580.
- Davis PL, Kaufman L, Crooks LE, Miller TR. Detectability of Hepatomas in Rat Livers by Nuclear Magnetic Resonance Imaging. Investigative Radiology 1981; 16: 354-359. PMID: 7287354.
- Brant-Zawadzki M, Davis PL, Crooks LE, Mills CM, Norman D, Newton TH, Sheldon P, Kaufman L. NMR Demonstration of Cerebral Abnormalities: Comparison with CT. American Journal of Neuroradiology 1983; 4:117-124. PMID: 6601423.
- Davis PL, Staiger MJ, Harris KB, Ganott MA, Klementaviciene J, McCarty KS Jr., Tobon H. Breast cancer measurements with magnetic resonance imaging, ultrasonography and mammography. Breast Cancer Research and Treatment 1996; 37:1-9. PMID: 8750522.
- Davis PL. Assessing the potential earnings versus the actual earnings of academic radiologists: the effects of unequal duty service assignments. Academic Radiology 2001; 8:782-791.
- Radiology: Plain films, fluoroscopy, CT, MRI, gastrointestinal radiology
- Image processing
- Machine learning
- Validity and Reliability of Medical Imaging
Principal investigator, co-principal investigator or co-investigator on 8 grants. These included grants from the National Institutes of Health (NIH), the Department of Defense Breast Cancer Research Program, and the Susan G. Komen Foundation.
Local principal investigator for seven phase III MRI contrast agent studies involving liver and breast cancers. These seven studies covered all the major types of MRI contrast agents presently used: Gadolinium (Gd) based vascular agents, Gd based liver agents (Gd-EOB-DTPA), and liver and lymph node specific non-Gd based agents including ferumoxides.